Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Heteroplasmic shifts in tumor mitochondrial genomes reveal tissue-specific signals of relaxed and positive selection.

Grandhi S, Bosworth C, Maddox W, Sensiba C, Akhavanfard S, Ni Y, LaFramboise T.

Hum Mol Genet. 2017 Aug 1;26(15):2912-2922. doi: 10.1093/hmg/ddx172.

2.

Clinical, Pathologic, and Genetic Features of Wilms Tumors With WTX Gene Mutation.

Alexandrescu S, Akhavanfard S, Harris MH, Vargas SO.

Pediatr Dev Pathol. 2017 Mar-Apr;20(2):105-111. doi: 10.1177/1093526616683881. Epub 2017 Jan 26.

PMID:
28326956
3.

Clinical, pathologic, and genetic features of Wilms tumors with WTX gene mutation.

Alexandrescu S, Akhavanfard S, Harris MH, Vargas SO.

Pediatr Dev Pathol. 2016 Jan 4. [Epub ahead of print]

PMID:
26727637
4.

Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.

Akhavanfard S, Vargas SO, Han M, Nitta M, Chang CB, Le LP, Fazlollahi L, Nguyen Q, Ma Y, Cosper A, Dias-Santagata D, Han JY, Bergethon K, Borger DR, Ellisen LW, Pomeroy SL, Haber DA, Iafrate AJ, Rivera MN.

Genes Chromosomes Cancer. 2014 Jan;53(1):67-77. doi: 10.1002/gcc.22118. Epub 2013 Nov 5.

PMID:
24249259
5.

Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.

Snuderl M, Fazlollahi L, Le LP, Nitta M, Zhelyazkova BH, Davidson CJ, Akhavanfard S, Cahill DP, Aldape KD, Betensky RA, Louis DN, Iafrate AJ.

Cancer Cell. 2011 Dec 13;20(6):810-7. doi: 10.1016/j.ccr.2011.11.005. Epub 2011 Dec 1.

6.

The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification.

Moisan A, Rivera MN, Lotinun S, Akhavanfard S, Coffman EJ, Cook EB, Stoykova S, Mukherjee S, Schoonmaker JA, Burger A, Kim WJ, Kronenberg HM, Baron R, Haber DA, Bardeesy N.

Dev Cell. 2011 May 17;20(5):583-596. doi: 10.1016/j.devcel.2011.03.013. Erratum in: Dev Cell. 2012 May 15;22(5):1109-17.

7.

Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms.

Xiao HD, Yamaguchi H, Dias-Santagata D, Kuboki Y, Akhavanfard S, Hatori T, Yamamoto M, Shiratori K, Kobayashi M, Shimizu M, Fernandez-Del Castillo C, Mino-Kenudson M, Furukawa T.

J Pathol. 2011 Aug;224(4):508-16. doi: 10.1002/path.2875. Epub 2011 May 5.

PMID:
21547907
8.

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.

Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, Akhavanfard S, Heist RS, Temel J, Christensen JG, Wain JC, Lynch TJ, Vernovsky K, Mark EJ, Lanuti M, Iafrate AJ, Mino-Kenudson M, Engelman JA.

Sci Transl Med. 2011 Mar 23;3(75):75ra26. doi: 10.1126/scitranslmed.3002003.

9.

Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers.

Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ, Contino G, Deshpande V, Iafrate AJ, Letovsky S, Rivera MN, Bardeesy N, Maheswaran S, Haber DA.

Science. 2011 Feb 4;331(6017):593-6. doi: 10.1126/science.1200801. Epub 2011 Jan 13.

10.

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine.

Dias-Santagata D, Akhavanfard S, David SS, Vernovsky K, Kuhlmann G, Boisvert SL, Stubbs H, McDermott U, Settleman J, Kwak EL, Clark JW, Isakoff SJ, Sequist LV, Engelman JA, Lynch TJ, Haber DA, Louis DN, Ellisen LW, Borger DR, Iafrate AJ.

EMBO Mol Med. 2010 May;2(5):146-58. doi: 10.1002/emmm.201000070.

11.

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

Turke AB, Zejnullahu K, Wu YL, Song Y, Dias-Santagata D, Lifshits E, Toschi L, Rogers A, Mok T, Sequist L, Lindeman NI, Murphy C, Akhavanfard S, Yeap BY, Xiao Y, Capelletti M, Iafrate AJ, Lee C, Christensen JG, Engelman JA, Jänne PA.

Cancer Cell. 2010 Jan 19;17(1):77-88. doi: 10.1016/j.ccr.2009.11.022.

12.

Decreased survival in EGFR gene amplified vulvar carcinoma.

Growdon WB, Boisvert SL, Akhavanfard S, Oliva E, Dias-Santagata DC, Kojiro S, Horowitz NS, Iafrate AJ, Borger DR, Rueda BR.

Gynecol Oncol. 2008 Nov;111(2):289-97. doi: 10.1016/j.ygyno.2008.07.038. Epub 2008 Sep 3.

PMID:
18768215

Supplemental Content

Loading ...
Support Center